 | Up a level |
Mohsen, Mona O.; Rothen, Dominik; Balke, Ina; Martina, Byron; Zeltina, Vilija; Inchakalody, Varghese; Gharailoo, Zahra; Nasrallah, Gheyath; Dermime, Said; Tars, Kaspars; Vogel, Monique; Zeltins, Andris; Bachmann, Martin F. (2021). Neutralization of MERS coronavirus through a scalable nanoparticle vaccine. NPJ vaccines, 6(1), p. 107. Springer Nature 10.1038/s41541-021-00365-w
Liu, Xuelan; Chang, Xinyue; Rothen, Dominik; Derveni, Mariliza; Krenger, Pascal; Roongta, Salony; Wright, Edward; Vogel, Monique; Tars, Kaspars; Mohsen, Mona O.; Bachmann, Martin F. (2021). AP205 VLPs Based on Dimerized Capsid Proteins Accommodate RBM Domain of SARS-CoV-2 and Serve as an Attractive Vaccine Candidate. Vaccines, 9(4) MDPI 10.3390/vaccines9040403
Bachmann, Martin; Zeltins, Andris; Kalnins, Gints; Balke, Ina; Fischer, Nina; Rostaher, Ana; Tars, Kaspars; Favrot, Claude (2018). Vaccination against IL-31 for the treatment of atopic dermatitis in dogs. The Journal of allergy and clinical immunology, 142(1), 279-281.e1. Elsevier 10.1016/j.jaci.2017.12.994
Pumpens, Paul; Renhofa, Regina; Dishlers, Andris; Kozlovska, Tatjana; Ose, Velta; Pushko, Peter; Tars, Kaspars; Grens, Elmars; Bachmann, Martin (2016). The True Story and Advantages of RNA Phage Capsids as Nanotools. Intervirology, 59(2), pp. 74-110. Karger 10.1159/000449503
